Reflections on relevance: Psychotherapy and psychosomatics in 2004

Psychotherapy and Psychosomatics

Volumn 74, Issue 1, 2005, Pages 3-9

  Balon, Richard ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UPC Jefferson   (United States)

Author keywords

Alexithymia; Cancer; Citation analysis; Clinimetrics; Depression; Fibromyalgia; Hypercoagulability; Impact factor; Nutrition

Indexed keywords

CITALOPRAM; COBALAMIN; D DIMER; ESCITALOPRAM; FIBRIN; FIBRINOGEN; FOLIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; PYRIDOXAL 5 PHOSPHATE;

ALEXITHYMIA; ANXIETY; CANCER; CANCER PATIENT; CHIMERA; CLINICAL FEATURE; CLINICAL TRIAL; COPING BEHAVIOR; DEPRESSION; DIETARY INTAKE; EMOTION; FIBROMYALGIA; HUMAN; HYPERCOAGULABILITY; MEDICAL RESEARCH; MENTAL DISEASE; NUTRITION; PANIC; PATIENT CARE; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOLOGY; PSYCHOMETRY; PSYCHOPHARMACOLOGY; PSYCHOSOMATICS; PSYCHOTHERAPY; PUBLICATION; QUALITY CONTROL; RATING SCALE; REVIEW; RISK FACTOR; SENSATION; SOCIAL PSYCHOLOGY; STATISTICAL SIGNIFICANCE; STRESS;

AFFECTIVE SYMPTOMS; ANXIETY; DEPRESSION; FIBROMYALGIA; HUMANS; NEOPLASMS; NUTRITION PHYSIOLOGY; PANIC DISORDER; PSYCHOPHARMACOLOGY; PSYCHOSOMATIC MEDICINE; PSYCHOTHERAPY; PUBLISHING; THROMBOPHILIA;

EID: 11844251230     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082020     Document Type: Review

References (29)

1. Balon R: Reflections on relevance: Psychotherapy and Psychosomatics in 2003. Psychother Psychosom 2004;73:5-9.
2. Fava GA, Guidi J, Sonino N: How citation analysis can monitor the progress of research in clinical medicine. Psychother Psychosom 2004;73:331-333.
3. Fava GA. The cult of mediocrity. Psychother Psychosom 2005;74:1-2.
4. Casey P: SSRI and suicide. Psychother Psychosom 2004;73:259-260.
5. Healy D: Reply. Psychother Psychosom 2004; 73:26-261.
6. Painuly N, Basu D: SSRI and suicide? Psychother Psychosom 2004;73:261-262.
7. Healy D: Reply. Psychother Psychosom 2004;73:262.
8. Healy D: Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom 2003;72:71-79.
9. Balon R: Selective serotonin reuptake inhibitors and suicide: Is the evidence, as with beauty, in the eye of the beholder? Psychother Psychosom 2003;72:293-299.
10. Van Houdenhove B, Egle UT: Fibromyalgia: A stress disorder? Piecing the biopsychosocial puzzle together. Psychother Psychosom 2004;73:267-275.
11. Williams DA: Psychosocial and behavioural therapies for fibromyalgia and related syndromes. Best Pract Res Clin Rheum 2003;17:649-665.
12. Honda K, Goodwin RD: Cancer and mental disorders in a national community sample: Findings from the National Comorbidity Survey. Psychother Psychosom 2004;73:235-242.
13. Anagnostopoulos F, Vaslamatzis G, Markidis M: Coping strategies of women with breast cancer: A comparison of patients with healthy and benign controls. Psychother Psychosom 2004;73:43-52.
14. Vos PJ, Garssen B, Visser AP, Duivenvoorden HJ, de Haes HCJM: Psychosocial intervention for women with primary, non-metastatic breast cancer: A comparison between participants and non-participants. Psychother Psychosom 2004;73:276-285.
15. Porcelli P, Affatati V, Bellomo A, De Carne M, Todarello O, Taylor GJ: Alexithymia and psychopathology in patients with psychiatric and functional gastrointestinal disorder. Psychother Psychosom 2004;73:84-91.
16. Graugaard PK, Holgersen K, Finset A: Communicating with alexithymic and non-alexithymic patients: An experimental study of the effect of psychosocial communication and empathy on patient satisfaction. Psychother Psychosom 2004;73:92-100.
17. Rufer M, Hand I, Braatz A, Alsleben H, Fricke S, Peter H: A prospective study of alexithymia in obsessive-compulsive patients treated with multimodal cognitive behavioral therapy. Psychother Psychosom 2004;73:101-106.
18. Taylor GJ, Bagby RM: New trends in alexithymia research. Psychother Psychosom 2004;73:68-77.
19. Ruxton C: Health benefits of omega-3 fatty acids. Nurs Stand 2004;18:38-42.
20. Naliwaiko K, Araujo RL, da Fonseca RV, Castilho JC, Andreatini R, Bellissimo MI, Oliveira BH, Martins EF, Curi R, Fernandes LC, Ferraz AC: Effects of fish oil on the central nervous system: A new potential antidepressant? Nutr Neurosci 2004;7:91-99.
21. Tolmunen T, Hintikka J, Ruusunen A, Voutilainen S, Tanskanen A, Valkonen V-P, Viinamaki H, Kaplan GA, Salonen JT: Dietary folate and the risk of depression in Finnish middle-aged men: A prospective follow-up study. Psychother Psychosom 2004;73:334-339.
22. 6 level is associated with symptoms of depression. Psychother Psychosom 2004;73:340-343.
23. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, Marzec U, Harker LA, Nemeroff CB: Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-1317.
24. von Kanel R: Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: How strong is the evidence? Acta Psychiatr Scand 2004;110:163-177.
25. von Kanel R, Kudielka BM, Schulze R, Gander M-L, Fischer JE: Hypercoagulability in working men and women with high level of paniclike anxiety. Psychother Psychosom 2004;73:353-360.
26. Svensson S, Mansfield PR: Escitalopram: Superior to citalopram or a chiral chimera? Psychother Psychosom 2004;73:10-16.
27. Moncrieff J, Churchill R, Drummond DC, Mcguire H: Development of a quality assessment instrument for trials of treatments for depression and neurosis. Int J Methods Psychiatry Res 2001;10:126-133.
28. Demyttenayere K, De Fruyt J: Getting what you ask for: On the selectivity of depression rating scales. Psychother Psychosom 2003;72:61-79.
29. Fava GA, Ruini C, Rafanelli C: Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom 2004;73:145-148.